Anti-FCN1/ FCNM functional antibody

Anti-FCN1/ FCNM functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to FCN1/FCN1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0210-Ab-1/ GM-Tg-hg-SE0210-Ab-2Anti-Human FCN1 monoclonal antibodyHuman
GM-Tg-rg-SE0210-Ab-1/ GM-Tg-rg-SE0210-Ab-2Anti-Rat FCN1 monoclonal antibodyRat
GM-Tg-mg-SE0210-Ab-1/ GM-Tg-mg-SE0210-Ab-2Anti-Mouse FCN1 monoclonal antibodyMouse
GM-Tg-cynog-SE0210-Ab-1/ GM-Tg-cynog-SE0210-Ab-2Anti-Cynomolgus/ Rhesus macaque FCN1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0210-Ab-1/ GM-Tg-felg-SE0210-Ab-2Anti-Feline FCN1 monoclonal antibodyFeline
GM-Tg-cang-SE0210-Ab-1/ GM-Tg-cang-SE0210-Ab-2Anti-Canine FCN1 monoclonal antibodyCanine
GM-Tg-bovg-SE0210-Ab-1/ GM-Tg-bovg-SE0210-Ab-2Anti-Bovine FCN1 monoclonal antibodyBovine
GM-Tg-equg-SE0210-Ab-1/ GM-Tg-equg-SE0210-Ab-2Anti-Equine FCN1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0210-Ab-1/ GM-Tg-hg-SE0210-Ab-2; GM-Tg-rg-SE0210-Ab-1/ GM-Tg-rg-SE0210-Ab-2;
GM-Tg-mg-SE0210-Ab-1/ GM-Tg-mg-SE0210-Ab-2; GM-Tg-cynog-SE0210-Ab-1/ GM-Tg-cynog-SE0210-Ab-2;
GM-Tg-felg-SE0210-Ab-1/ GM-Tg-felg-SE0210-Ab-2; GM-Tg-cang-SE0210-Ab-1/ GM-Tg-cang-SE0210-Ab-2;
GM-Tg-bovg-SE0210-Ab-1/ GM-Tg-bovg-SE0210-Ab-2; GM-Tg-equg-SE0210-Ab-1/ GM-Tg-equg-SE0210-Ab-2
Products NameAnti-FCN1 monoclonal antibody
Formatmab
Target NameFCN1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-FCN1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0210-Ag-1Recombinant multi-species FCN1/ FCNM protein


    Target information

    Target IDGM-SE0210
    Target NameFCN1
    Gene ID2219,14134,114091
    Gene Symbol and SynonymsFCN1,Fcn2,Fcnb,FCNM
    Uniprot AccessionO00602,P57756
    Uniprot Entry NameFCN1_HUMAN,FCN2_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000085265
    Target ClassificationN/A

    The target: FCN1, gene name: FCN1, also named as FCNM. The ficolin family of proteins are characterized by the presence of a leader peptide, a short N-terminal segment, followed by a collagen-like region, and a C-terminal fibrinogen-like domain. The collagen-like and the fibrinogen-like domains are also found separately in other proteins such as complement protein C1q, C-type lectins known as collectins, and tenascins.  However, all these proteins recognize different targets, and are functionally distinct.  Ficolin 1 encoded by FCN1 is predominantly expressed in the peripheral blood leukocytes, and has been postulated to function as a plasma protein with elastin-binding activity. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.